NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-205-2006-2-GB-25 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure GB EP 07813996.1 Issued
NIA E-205-2006-2-EP-06 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure EP National Stage 07813996.1 Issued
NIA E-205-2006-2-FR-24 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure FR EP 07813996.1 Issued
NIA E-205-2006-2-DE-23 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure DE EP 07813996.1 Issued
NIA E-205-2006-2-IL-07 Preparation Of R,R-fenoterol And R,R- or R,S- fenoterol Analogues And Their Use In Congestive Heart Failure IL National Stage 196965 Issued
NIA E-205-2006-2-MX-11 Preparation of (R,R)-fenoterol And (R,R)- Or (R,S)-fenoterol Analogues And Their Use In Treating Congestive Heart Failure MX National Stage MX/A/2009/001534 Issued
NIA E-205-2006-2-IN-08 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure IN National Stage 457/KOLNP/2009 Issued
NIA E-205-2006-2-CA-04 Preparation Of (R,R)-Fenoterol And (R,R)- Or (R,S)- Fenoterol Analogues And Their Use In Treating Congestive Heart Failure CA National Stage 2660707 Issued
NIA E-205-2006-2-KR-10 Preparation Of (R,R)-Fenoterol And (R,R)- or (R,S)-fenoterol Analogues And Their Use In Congestive Heart Failure KR National Stage 10-2009-7002634 Issued
NIA E-205-2006-2-CN-05 Preparation Of R,R-fenoterol And (R,R)- OR (R,S)- Fenoterol Analogues And Their Use In Treating Congestive Heart Failure CN National Stage 200780036155.9 Issued
NIA E-205-2006-2-JP-09 Preparation Of (R,R)-fenoterol And (R,R)- or (R,S)-fenoterol Analogues And Their Use In Congestive Heart Failure JP National Stage 2009-524015 Issued
NIA E-205-2006-2-AU-02 Preparation Of (R,R)-fenoterol And (R,R)- or (R,S)-fenoterol Analogues And Their Use in Treating Congestive Heart Failure AU National Stage 2007286051 Issued
NIA E-205-2006-2-ZA-14 Preparation of (R,R)-fenoterol And (R,R)- Or (R,S)-fenoterol Analogues And Their Use In Treating Congestive Heart Failure ZA National Stage 2009/00938 Abandoned
NICHD E-304-2005-0-PCT-02 Methods for Treatment and Diagnosis of Psychiatric Disorders PCT PCT PCT/US2007/75724 Expired
NIA E-205-2006-2-PCT-01 Preparation of (R,R)-fenoterol And (R,R)- Or (R,S)-fenoterol Analogues And Their Use In Treating Congestive Heart Failure PCT PCT COMB PCT/US2007/075731 Expired
NIAID E-123-2005-1-US-02 HIV Gp41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles As Novel Antigens US National Stage 11/816,069 Abandoned
NCI E-251-2004-0-US-03 Broadly Cross-reactive HIV -1 Neutralizing Human Monoclonal Antibodies US ORD 11/718,202 Abandoned
NIA E-205-2006-2-CN-18 Preparation Of R,R- Fenoterol And R,R OR R,S Fenoterol Analogues And Their Use In Treating Congestive Heart Failure CN DIV 201310705914.3 Abandoned
NIA E-205-2006-2-PH-12 Preparation Of R,R-fenoterol And R,R-fenoterol Or R,S-fenoterol Analogues And Their Use In Treating Congestive Heart Failure PH National Stage 1-2009-500267 Abandoned
NIAID E-019-2007-2-CA-04 Influenza Hemagglutinin and Neuraminidase Variants CA National Stage 2659267 Abandoned
NIAID E-019-2007-2-KR-15 Influenza Hemagglutinin and Neuraminidase Variants KR DIV 10-2014-7013573 Abandoned
NIAID E-019-2007-2-AU-03 Vaccines Against Potential Pandemic Strains Of Influenza AU National Stage 2007286161 Abandoned
NIAID E-019-2007-2-PCT-01 Vaccines Against Potential Pandemic Strains Of Influenza PCT PCT COMB PCT/US2007/075585 Expired
NIAID E-019-2007-2-US-02 Influenza Hemagglutinin And Neuraminidase Variants US ORD 11/836,413 Abandoned
NIAID E-019-2007-2-CN-17 Influenza Hemagglutinin and Neuraminidase Variants CN DIV 201410269606.5 Abandoned
NIAID E-019-2007-2-EP-06 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS EP National Stage 07840814.3 Abandoned
NIAID E-019-2007-2-JP-19 Influenza Hemagglutinin and Neuramindase Variants JP DIV 2015-093758 Abandoned
NIAID E-019-2007-2-JP-20 Influenza Hemagglutinin and Neuramindase Variants JP DIV 2015-093759 Abandoned
NIAID E-019-2007-2-IN-07 Vaccines Against Potential Pandemic Strains Of Influenza IN National Stage 860/DELNP/2009 Abandoned
NCI E-090-2009-2-US-01 High-Throughput Minimally Invasive Radiation Biodosimetry US 60/954,499 Abandoned
NHLBI E-257-2005-0-DE-08 Wide-area Fluorescence Detection System For Two-photon Microscopy DE EP 07811119.2 Issued
NHLBI E-257-2005-0-FR-09 Wide-area Fluorescence Detection System For Two-photon Microscopy FR EP 07811119.2 Issued
NHLBI E-257-2005-0-EP-05 Wide-area Fluorescence Detection System For Two-photon Microscopy EP National Stage 07811119.2 Issued
NHLBI E-257-2005-0-CH-07 Wide-area Fluorescence Detection System For Two-photon Microscopy CH EP 07811119.2 Issued
NHLBI E-257-2005-0-GB-10 Wide-area Fluorescence Detection System For Two-photon Microscopy GB EP 07811119.2 Issued
NHLBI E-257-2005-0-PCT-02 Wide-area Fluorescence Detection System For Two-photon Microscopy PCT PCT PCT/US2007/17478 Expired
NCI E-099-1989-0-US-30 METHODS FOR IDENTIFYING ALPHA PDGFR AGONISTS AND ANTAGONISTS US DIV 11/834,541 Abandoned
NHLBI E-257-2005-0-AU-06 Wide-area Fluorescence Detection System For Two-photon Microscopy AU National Stage 2007281902 Abandoned
NIAID E-089-1997-2-AU-13 PRODUCTION OF ATTENTUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES AU DIV 2007203671 Abandoned
NICHD E-181-2004-0-US-07 NANDROLONE 17B-CARBONATES US National Stage 11/815,532 7820642 Issued PDF
NINDS E-002-2009-0-US-01 Use Of Phosphatases To Treat Neuroblastomas And Medulloblastomas US 60/963,307 Abandoned
NCI E-150-2007-0-US-01 COMPOSITIONS AND METHODS FOR TREATING PIGMENTARY CONDITIONS AND MELANOMA US 60/963,280 Abandoned
NIAID E-270-2004-0-JP-04 Method to Predict and Prevent Oxygen-Induced Inflammatory Tissue Injury JP National Stage 2007-554143 Pending
NCI E-085-2003-2-US-09 Cyanoviran Variant-Polymer Conjugates US DIV 11/832,925 7547509 Expired PDF
NIAID E-289-2007-0-US-01 Methods for Detecting and Prevention of Tick Infestation and Pathogen Transmission US 60/963,332 Abandoned
NCI E-297-2007-0-US-01 Differentiation-induction And Chemosensitizing Therapy Of Cancer Using Tissue Inhibitor Of Matrix Metalloproteinases-2 (TIMP-2) Mutants And Peptides US 60/953,352 Abandoned
NIMH E-268-2007-0-US-01 A Fold-back Diabody Format For Diptheria Toxin Based Immunotoxins That Can Increase Binding And Potentcy With Particular Application To An Anti-prostratic Cancer Immunotoxin A-dmDT390scfbDb(591) US 60/953,416 Abandoned
NIDCR E-268-2002-0-US-03 RECOMBINANT MODIFIED BACILLUS ANTHRACIS PROTECTIVE ANTIGEN FOR USE IN VACCINES US DIV 11/831,860 8394387 Issued PDF
NIEHS E-103-2000-3-PCT-02 Biologically Potent Analogues of the Dmt-Tic Pharmocophore And Methods of Use PCT PCT PCT/US07/074839 Expired
NIAID E-161-2007-0-US-01 Treatment Of Primary Tumors And Tumor Metastases With TNF-alpha Antagonists US 60/962,668 Abandoned